ZNF451 was significantly associated with most of the infiltrating cells, suggesting its potential influence on osteosarcoma treatment outcomes by modulating the immune microenvironment, as shown in Fig. 6C. Consistent with previous studies, patients with high CD8+ T cell expression demonstrated a markedly improved prognosis (Fig. 6D). Here, ZNF451 is linked to osteosarcoma.